Help us to defend our title as the Best Science and Medicine Podcast! Go to podcastawards.com and select “DNA Today” in the Science and Medicine category. Bonus if you tweet/post that you nominated DNA Today (and tag us), then we will share your post and give you a shoutout on the show as a thank you. You have the power to get DNA Today nominated again! Our guest this week is Dr.Tod Klingler, who is the head of product research and development at Genomic Life. Over his 25-year career, Dr. Klingler has held leadership roles with organizations that have successfully developed and commercialized innovative products including Illumina, Roche, XDx (now CareDx) and Incyte. Dr. Klingler has also founded start-up companies such as Prospect Genomics and Station X. On this episode, he shares insights from his decades long career in the industry! Disclaimer: DNA Today is sponsored by some genetic companies. You can view the full list of DNA Today sponsors at DNApodcast.com/sponsors. Since we are both US based our conversation will focus on the industry in America. On This Episode We Discuss: Changes in genetic testing trends over the last few decades The benefits of companies shifting from specializing in specific types of genetic tests to expanding into multiple areas of genetics How laws, professional organization guidelines/recommendations and insurance changes affect genetic testing labs The role of genetic counseling companies in the future Types of genetic testing (ex: Liquid Biopsies, PRS, WGS) Advice for genomic companies on best practices to become successful Recommendations for resources for people to keep up with industry changes In this episode, Tod shared some recommendations for resources for people to keep up with all of these genetic testing industry changes which you can access here: GenomeWeb, GA for GH, and Genome.gov! You can also check out the PGx legislation and HR 2144 that were mentioned during the interview. Stay tuned for the next new episode of DNA Today on August 5th, 2022 ! New episodes are released on Fridays. In the meantime, you can binge over 190 other episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Today”. Episodes since 2021 are also recorded with video which you can watch on our YouTube channel. DNA Today is hosted and produced by Kira Dineen. Our social media lead is Corinne Merlino. Our video lead is Amanda Andreoli. See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, DNApodcast.com. Questions/inquiries can be sent to [email protected]. PerkinElmer Genomics is a global leader in genetic testing focusing on rare diseases, inherited disorders, newborn screening, and hereditary cancer. Testing services support the full continuum of care from preconception and prenatal to neonatal, pediatric, and adult. Testing options include sequencing for targeted genes, multiple genes, the whole exome or genome, and copy number variations. Using a simple saliva or blood sample, PerkinElmer Genomics answers complex genetic questions that can proactively inform patient care and end the diagnostic odyssey for families. Learn more at PerkinElmerGenomics.com. (SPONSORED)

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related